Goal
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: the POST trial / Luca Livraghi, F.M.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - ELETTRONICO. - 213:(2024), pp. 0-0.
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: the POST trial
Simonetta Bianchi;
2024
Abstract
Goal
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2024 Livraghi et al EJC.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.72 MB
Formato
Adobe PDF
|
1.72 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
